arrow
C

Claus L. Andersen

Aarhus University Hospital
H指数:60
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular residual disease assessment in colorectal and bladder cancer by somatic structural variant analysis of cell-free DNA whole-genome sequencing data

通过游离DNA全基因组测序数据的体细胞结构变异分析评估结直肠癌和膀胱癌的分子残留病灶

2026-02-090
OA
Cross-dataset pan-cancer detection by correlating cell-free DNA fragment coverage with open chromatin sites across cell types

通过关联细胞自由DNA片段覆盖度与跨细胞类型的开放染色质位点,进行跨数据集泛癌检测

2025-11-210
OAAI
Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

分子病理学家液体活检教育的视角:迈向整合、公平和去中心化的精准肿瘤学

2025-11-010
OAAI
High torque Teno virus load is associated with increased all-cause mortality risk in liver transplant recipients: a multicenter cohort study

高转矩Teno病毒载量与肝移植受者全因死亡风险增加相关:一项多中心队列研究

2025-10-010
OAAI
Whole-genome sequencing of cell-free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas

无细胞DNA的全基因组测序揭示了结直肠腺瘤患者血浆中肿瘤来源的DNA

2025-01-200
OA
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients

通过肿瘤知情全基因组测序检测循环肿瘤DNA可以预测III期结直肠癌患者的复发

2024-11-010
OAAI
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
2024-10-100
OA
Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma

全基因组突变分析用于尿路上皮癌患者循环肿瘤DNA的肿瘤知情检测

2024-10-012
OA
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

使用机器学习引导的信号富集技术对基于血浆的肿瘤负荷进行超灵敏监测

2024-06-144
OAAI